Basel, Switzerland

Thomas Holbro

USPTO Granted Patents = 3 

 

 

Average Co-Inventor Count = 2.0

ph-index = 2

Forward Citations = 4(Granted Patents)


Company Filing History:


Years Active: 2016-2021

Loading Chart...
Loading Chart...
Loading Chart...
3 patents (USPTO):

Title: The Innovative Mind of Thomas Holbro

Introduction

Thomas Holbro, an accomplished inventor based in Basel, Switzerland, has made significant contributions to the field of pharmaceuticals through his innovative ideas and patents. With a total of three patents to his name, he has established himself as a notable figure in medical research, particularly in the treatment of conditions associated with atrial enlargement and remodeling.

Latest Patents

Holbro's latest inventions focus on inhibitors for treating diseases characterized by atrial enlargement or remodeling. One of his key patents is for the NEP inhibitor pro-drug identified as N-(3-carboxy-1-oxopropyl)-(4S)-p-phenylphenylmethyl)-4-amino-(2R)-methylbutanoic acid ethyl ester. This compound, along with its pharmaceutically acceptable salt variants, is designed for the treatment, prevention, or delay of progression of related diseases. The inventive methods encompass administering a therapeutically effective or prophylactically effective amount of the NEP inhibitor or its pro-drug to human subjects in need of treatment. Furthermore, his patent includes details about pharmaceutical compositions or commercial packages incorporating these innovative inhibitors for medical use.

Career Highlights

Thomas Holbro is currently associated with Novartis AG, a leading global healthcare company known for its innovative medicines. His role at the company allows him to further his research and development efforts in the field of medicine, particularly while working on targeted therapies that can significantly improve patients' quality of life.

Collaborations

Throughout his career, Holbro has collaborated with notable professionals within the industry, including his coworker Christoph Schumacher. Their partnership has likely enhanced the research and development dynamics within their projects, contributing to the successful advancement of their innovative ideas.

Conclusion

In summary, Thomas Holbro exemplifies the spirit of innovation in the pharmaceutical industry. His work on NEP inhibitors showcases his commitment to addressing serious medical conditions, highlighting the vital role inventors play in advancing healthcare solutions. Through his collaborations and position at Novartis AG, he continues to make strides that could lead to significant improvements in patient care and treatment methodologies.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…